ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Blue Chip Shares
3 incredible Australian stocks I would buy and hold forever
Blue Chip Shares
3 of the best ASX 200 blue chip shares to buy now
Broker Notes
Rate cut winners in the ASX 200 to add to your portfolio
Growth Shares
Where to invest $10,000 in ASX shares in September
How to invest
Why you should buy ASX shares instead of US stocks right now
How to invest
How to make $1,000 a month in passive income with ASX shares
How to invest
How to double your money in the ASX share market
Growth Shares
3 ASX growth shares to buy and hold
How to invest
How much will I have if I invest $1,000 a month in ASX shares for 30 years?
How to invest
How to build a million-dollar ASX share portfolio in 25 years
Blue Chip Shares
3 no-brainer Australian stocks to buy with $7,000 right now
Growth Shares
The best ASX growth shares to hold for the next decade
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.